TCAR Insights

The TCAR Revolution

Peter A. Schneider, MD. Supplement to Endovascular Today, August 2019

Challenging Case: The Consequence of Unmanaged Hypotension After TCAR

Angela A. Kokkosis, MD, FACS, RPVI. Supplement to Endovascular Today, August 2019

Challenging Case: Retrograde TCAR for Symptomatic Proximal Common Carotid Stenosis

Peter Rossi, MD, FACS, FSVS. Supplement to Endovascular Today, August 2019

Challenging Case: Acute Thrombosed Carotid Stent Recanalization

Inkyong K. Parrack, MD and Russell H. Samson, MD, DFSVS. Supplement to Endovascular Today, August 2019

The Evidence Base Dictating Practice in Patients With Concomitant Significant Coronary Artery and Carotid Artery Disease

Sumaira Macdonald, MD, PhD, MBChB, MRCP, FRCP, FRCR; Richard P. Cambria, MD; and Douglas Massop, MD. Supplement to Endovascular Today, August 2019

Vascular Quality Initiative: Transcarotid Stenting Project Update

Marc Schermerhorn, MD and Patric Liang, MD. Supplement to Endovascular Today, August 2019

TCAR Pearls and Pitfalls

Michael C. Stoner, MD, RVT, FACS and Jeffrey Jim, MD, MPHS, FACS. Supplement to Endovascular Today, August 2019

TCAR TEST Drive

Wesley S. Moore, MD and Michael C. Stoner, MD, RVT, FACS. Supplement to Endovascular Today, August 2019

Identifying Clopidogrel Resistance in the Setting of TCAR

Edgar D. Guzman, MD FACS, RPVI and Jessica Titus, MD. Supplement to Endovascular Today, August 2019

TCAR: Reversing Flow to Move Carotid Surgery Forward

Siddharth Patel, MD. Vascular Disease Management, May 2019

The Shifting Paradigm in Carotid Revascularization: TCAR in Real-World Practice

Marc Schermerhorn, MD; Patric Liang, MD; and Bernardino C. Branco Rocha, MD. Endovascular Today, May 2019

Transcarotid artery revascularization beneficial in real-world population.

Marc L. Schermerhorn, MD. Cardiology Today’s Intervention, December 2018

TCAR: The Next Step in the Evolution of Carotid Revascularization.

Jeffrey Jim, MD, MPHS, FACS. Supplement to Endovascular Today, August 2018

Optimal Pharmacologic Strategy for TCAR: An Expert Panel Discussion.

Michael R. Jaff, DO; Sumaira Macdonald, MBChB (Comm), MD, FRCP, FRCR, PhD; Richard Cambria, MD; et al.
Supplement to Endovascular Today, August 2018

Periprocedural Hemodynamic Management for TCAR

Michael R. Jaff, DO; Angela A. Kokkosis, MD; José Ignacio Leal, MD, PhD; and Sumaira Macdonald, MBChB (Comm), MD, FRCP, FRCR, PhD. Supplement to Endovascular Today, August 2018

Reimbursement and Future Coverage for Transcarotid Artery Revascularization.

Louis Jacques, MD; and Marc L. Schermerhorn, MD. Supplement to Endovascular Today, August 2018

TCAS with dynamic flow reversal demonstrates embolisation rates comparable to CEA*

Maarten Plessers, MSc. Vascular News, April 2016

Is CAS a Reasonable Alternative to CEA?

Wesley Moore, MD
Vascular Specialist April 2016 page 2

Avoiding the Aortic Arch and Using Flow Reversal: CAS with the SRM System to Reduce Stroke.

Richard Cambria, MD. Cath Lab Digest. 2014. April: 22(4):12,14

An Overview of the ROADSTER Trial.

Christopher J. Kwolek, MD, and Richard M. Ruedy. Endovascular Today. 2013. Sept.

* The ENROUTE NPS and Stent Systems are approved for use in the EU in patients at standard risk for complications from CEA. These indications have not been evaluated by the US FDA.

The links on this page take you away from the Silk Road Medical website. These websites are not operated by Silk Road Medical. Silk Road Medical does not control the content of these websites.